Pilot Evaluation of a Microfluidic Assay to Detect Minimal Residual Disease and Predict Relapse in AML Patients

Clinical trial NCT03488862 · COMPLETED

Trial details

NCT number: NCT03488862
Sponsor: UNC Lineberger Comprehensive Cancer Center
Status: COMPLETED
Study type: OBSERVATIONAL

Acute Myeloid Leukemia

Start date: 2018-03-01
Primary completion: 2020-10-28
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.